{"id":"https://genegraph.clinicalgenome.org/r/bfea5491-af30-4e6b-8e95-a7cfff26b7d3v2.1","type":"EvidenceStrengthAssertion","dc:description":"There is a definitive association between alteration of the SOS1 gene and the Noonan syndrome (NS) phenotype. The maximum amount of scorable genetic evidence has been published showing that de novo and segregating variants occur in patients with NS (Lepri et al., 2011; Louati et al., 2014; Moncini et al., 2015; Narumi et al., 2007; Roberts et al., 2007; Tartaglia et al., 2007). The SOS1 gene is also located in the Ras/MAPK pathway which is associated with the NS phenotype(Aoki et al., 2016; Rauen, 2013). Of note, SOS1 has also been classified as disputed in association with cardiofaciocutaneous syndrome and Costello syndrome. The ClinGen RASopathy Gene Curation Expert Panel found no evidence associating SOS1 with either NS with loose anagen hair or NS with multiple lentigines. This curation was approved by the ClinGen RASopathy GCEP on 7/24/18 (SOP Version 5).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/bfea5491-af30-4e6b-8e95-a7cfff26b7d3","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:sopChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10021","date":"2021-03-04T20:49:18.177Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10021","date":"2018-07-24T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b78e658f-974e-4423-8a92-9e35341b481f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b7189ce-dc83-42b6-bbde-5138d4ca153e","type":"Finding","dc:description":"The SOS1 gene  is involved in the RAS/MAPK pathway which is connected to the RASoathies  which include NS. Therefore, it is implicated","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23875798","rdfs:label":"SOS1 in RAS/MAPK pathway","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed4a0561-6bdb-4298-92f0-994e2dbd4d8d","type":"EvidenceLine","dc:description":"THis doesn't provde direct support for the curation.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a2951c8-0b59-433d-9b1e-e9455d3012f7","type":"FunctionalAlteration","dc:description":"The variant caused a significant increase in the activation of ERK in the presence of EGF.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25712082","rdfs:label":"ERK activation with variants"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a3139155-13d3-4777-99c2-269e67fbb4d5","type":"EvidenceLine","dc:description":"This doesn't provide direct support for this gene's association with NS but does provide evidence for the pathogenicity of the variants.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4551b2ef-d2d3-4ae0-95e7-77831cefe689","type":"FunctionalAlteration","dc:description":"They showed that several variants across multiple domains in the protein have significant effects on the protein's function specific to the domains in which the variants are located.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20133692","rdfs:label":"crystal structure of SOS1 protein w/ assays on several varia"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e280d171-036b-49c9-a3b0-db58bdf82aeb","type":"EvidenceLine","dc:description":"This experiment provides support for the pathogenicity of the variants but not necessarily the curation","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f6cc841-1780-4c73-ad8b-ebbffb9d7aaf","type":"FunctionalAlteration","dc:description":"The study showed that the M269R, D309Y, R552G, and E846K variants all significantly increased the activation of ERK. The Y337C variant protein was shown to be unstable.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17143285","rdfs:label":"SOS1 variants (5)"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cb269943-4414-4fb8-9964-1a417e8e86fd","type":"EvidenceLine","dc:description":"This may provide support for the pathogenicity of the variants but doesn't provide support directly for the curation.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c10496e-6188-4dc9-ba01-d8227e8770a6","type":"FunctionalAlteration","dc:description":"The R552G variant protein significantly increased the basal level of active RAS and RAS activation after EGF stimulation. The W729L variant constitutively activated RAS.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17143282","rdfs:label":"SOS1 varaints (2)"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/400981d9-6543-4bb9-8585-711c9c9f9546","type":"EvidenceLine","dc:description":"This model is consistent with RASoapthies but not necessarily NS exclusively","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c6cec87-3730-4d0a-8c2e-5233ee603d10","type":"Finding","dc:description":"cardiac abnormalities are consistent","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21041952","rdfs:label":"SOS1 GOF mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f533589-9f65-4f63-a53a-a393a8e00a04_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This mutation was found to be de novo by Tartaglia et al. 2007.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bfecde46-a7c5-4af5-aa98-9bb957f24070","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25337068","rdfs:label":"Patient 7","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"phenotypeFreeText":"short stature; global developmental delay; triangular face; webbed neck; hypertelorism; curly hair; low-set ears","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4f533589-9f65-4f63-a53a-a393a8e00a04_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25337068","allele":{"id":"https://genegraph.clinicalgenome.org/r/c4c540d6-ec5f-42ee-a29a-f44880a2db48","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.1655G>A (p.Arg552Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/40683"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f80adf19-5bec-4ff6-8992-b92fe8a33fff_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant segregated with disease in Tartaglia et al. 2007. No family data was shown.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8dd73f3e-891a-4de7-afc3-1908b230f17e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25337068","rdfs:label":"Patient 6","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"phenotypeFreeText":"short stature; hypertelorism; high forehead; short neck","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f80adf19-5bec-4ff6-8992-b92fe8a33fff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25337068","allele":{"id":"https://genegraph.clinicalgenome.org/r/4da03121-0c12-409d-b130-2d6d774532a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.1294T>C (p.Trp432Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12873"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/13a77330-da4f-42ae-a97f-fba98fa75bf7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This study screened 24 patients with NS and 30 with CFC for variants in HRAS KRAS BRAF and MAP2K1/2. They identified SOS1 variants in 2 individuals with NS. Both variants were absent from 105 ethnically matched controls.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ccad7e3-b2fc-4c79-8947-70382a1c5a4b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18651097","rdfs:label":"NS13 III - 2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":35,"phenotypeFreeText":"hypertelorism; ptosis; downslanted palpebral fissures; low-set ears; short stature; pulmonic stenosis; atria septal defect; bulbous nose; underdeveloped nasal alae; long philtrum","previousTesting":true,"previousTestingDescription":"Both mother and daughter. 1 unaffected. See Fig 1a for pedigree.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/13a77330-da4f-42ae-a97f-fba98fa75bf7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18651097","allele":{"id":"https://genegraph.clinicalgenome.org/r/04ba881c-afe1-45a6-9fa7-b620fcf4005c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000492.4(CFTR):c.744-9_744-6del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/43579"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7a3401c1-e9a6-4927-bbfc-58c6c3af380e_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This study screened a 9 y/o girl with Noonan syndrome for variants in known NS genes using dye terminator sequencing. They identified the p.Ile252Thr variant in the proband as well as two of her family members with features of NS.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7096b92-2609-4d78-acaf-d099ef81545f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25712082","rdfs:label":"III-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"phenotypeFreeText":"relative macrocephaly; ptosis; strabismus; micrognathia; webbed neck; multiple cafÃ©-au-lait spots; multiple pigmented freckles; vitiligo; borderline intellectual disability; muscular hypotonia of the trunk; cutis marmorata; high forehead; arachnoid cyst","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7a3401c1-e9a6-4927-bbfc-58c6c3af380e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25712082","allele":{"id":"https://genegraph.clinicalgenome.org/r/52e0e989-ce48-4e00-b8dd-8f5a5b764a82","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.755T>C (p.Ile252Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1624725"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f5c2e4b7-42fc-475d-8243-d5b959a7dff2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant was functionally characterized by Roberts et al. 2007.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d167fe2-ab40-45a3-b08a-20b3f363cbe0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18651097","rdfs:label":"NS45","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"phenotypeFreeText":"pulmonic stenosis; hypertelorism; downslanted palpebral fissures; ptosis; low-set ears; low posterior hairline; abnormality of the sternum; cubitus valgus; short neck; webbed neck; broad neck","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f5c2e4b7-42fc-475d-8243-d5b959a7dff2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18651097","allele":{"id":"https://genegraph.clinicalgenome.org/r/8939978d-82f6-47cc-b031-d793dd37a8be","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.2536G>A (p.Glu846Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261734"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/678327d5-d980-4809-ac34-2e488be6f838_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/21268d51-ef69-4e8a-aa13-654445008b88","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21387466","rdfs:label":"NS19","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"phenotypeFreeText":"failure to thrive; short stature; delayed skeletal maturation; high forehead; narrow forehead; prominent supraorbital ridges; downslanted palpebral fissures; hypertelorism; epicanthus; depressed nasal bridge; wide nasal bridge; wide mouth; thick vermilion border; low-set ears; thickened helices; large ear lobe; micrognathia","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/678327d5-d980-4809-ac34-2e488be6f838_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21387466","allele":{"id":"https://genegraph.clinicalgenome.org/r/25015f45-99ec-4441-883a-507ec34918fc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.1310T>C (p.Ile437Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/45345"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/cb5c79b2-d3a9-412c-93b8-8e9a33176a0b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This study screened 91 patients with NS for variants in candidate NS genes using dye terminator sequencing. They identified SOS1 variants in 14 probands. They also functionally characterized five of these variants by measuring their ability to activate ERK.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fff21381-32f2-4230-bbc8-4eb58f97b6e9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17143285","rdfs:label":"Proband 4","ageUnit":"Years","ageValue":4,"detectionMethod":"Variant is de novo.","phenotypeFreeText":"pulmonic stenosis; cryptorchidism; abnormal facial shape","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cb5c79b2-d3a9-412c-93b8-8e9a33176a0b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17143285","allele":{"id":"https://genegraph.clinicalgenome.org/r/48e7e3ea-c83c-4b88-ae68-151e459c5ebd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.925G>T (p.Asp309Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/45379"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/524959b4-0174-46b9-abbf-7f8426b2ad34_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/162d3b1b-a94f-40eb-ba96-b68b83414dfc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21387466","rdfs:label":"NS23","phenotypeFreeText":"prominent supraorbital ridges; hypertelorism; ptosis; deep philtrum; thick vermilion border; wide mouth; low-set ears; thickened helices","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/524959b4-0174-46b9-abbf-7f8426b2ad34_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21387466","allele":{"id":"https://genegraph.clinicalgenome.org/r/e3433c00-bec9-424a-bab3-fbbb29d82f80","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.1300_1301delinsAA (p.Gly434Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/40671"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e9f0ce78-7c19-4251-ad14-800bea0ab1d4_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This study screened 91 patients with NS for variants in candidate NS genes using dye terminator sequencing. They identified SOS1 variants in 14 probands. They also functionally characterized five of these variants by measuring their ability to activate ERK.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8abe2502-3d96-409e-8d4e-96fbcd7eefaf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17143285","rdfs:label":"Proband 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"phenotypeFreeText":"hypertrophic cardiomyopathy; short stature; thrombocytopenia; bruising susceptibility; abnormal facial shape","previousTesting":true,"previousTestingDescription":"Variant is de novo.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e9f0ce78-7c19-4251-ad14-800bea0ab1d4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17143285","allele":{"id":"https://genegraph.clinicalgenome.org/r/ff3fda90-bb43-4e4f-928e-c2c835173856","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.797C>A (p.Thr266Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12869"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/de301c64-53d3-4d3d-835f-eb7f04d20fb3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This study screened 91 patients with NS for variants in candidate NS genes using dye terminator sequencing. They identified SOS1 variants in 14 probands. They also functionally characterized five of these variants by measuring their ability to activate ERK.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ba45f2f-8868-4456-8b14-84fc57e9c9ce","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17143285","rdfs:label":"Proband 2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":11,"phenotypeFreeText":"pulmonic stenosis; atria septal defect; short stature; cryptorchidism; abnormal facial shape","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/de301c64-53d3-4d3d-835f-eb7f04d20fb3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17143285","allele":{"id":"https://genegraph.clinicalgenome.org/r/5f1cb975-f6a1-4f17-a0ad-a4944fedfa94","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.806T>G (p.Met269Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12870"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":10}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":2127,"specifiedBy":"GeneValidityCriteria5","strengthScore":13,"subject":{"id":"https://genegraph.clinicalgenome.org/r/yp0aoOjSw2Q","type":"GeneValidityProposition","disease":"obo:MONDO_0018997","gene":"hgnc:11187","modeOfInheritance":"obo:HP_0000006"},"version":"2.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}